Arris, Bayer deal

The partners amended their 1994 agreement covering tryptase inhibitors, allowing ARRS to reacquire rights to the agents for inflammatory

Read the full 193 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE